相关实验视频
Updated: Jan 10, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
24.2K
心力衰竭对减肥手术术术后结果的影响
Kyle B LaPenna1, Florina Corpodean2, Celestino Castanon3
1Department of Surgery, Louisiana State University, New Orleans, Louisiana; Department of Medicine, Weill Cornell Medicine, New York City, New York.
概括
患有心力衰竭 (HF) 的患者在减肥手术后面临更高的术后并发症风险. 术前优化和仔细监测对于这些患者至关重要.
科学领域:
- 腹部外科手术的结果
- 心脏病学与新陈代谢健康
- 手术并发症 手术并发症
背景情况:
- 心力衰竭 (HF) 患病率不断上升,需要了解其对代谢和减肥手术结果的影响.
- 代谢综合征经常与HF共存,进一步复杂化了手术风险评估.
研究的目的:
- 为了评估心力衰竭 (HF) 病史和在代谢和减肥手术后的术后发病率之间的关联.
- 测试HF增加这些程序后不良结果的风险的假设.
主要方法:
- 使用了代谢和腹部外科认证和质量改进计划数据库 (2023).
- 采用1:1的倾向匹配来比较3422名患有HF的患者与3422名没有HF的患者.
- 评估了30天的综合结果,包括长时间逗留 (LOS>5天),感染并发症,严重并发症,主要的心血管和脑血管不良事件和死亡率.
主要成果:
- 心力衰竭患者的长期LOS>5天 (4.49%对1.66%,P<.001) 的比率显着更高.
- 在HF患者中,感染性并发症 (3.07%对1.72%,P<.001) 和严重并发症 (5.26%对2.70%,P<.001) 的发病率增加.
- 两组之间在主要不良心血管事件或30天死亡率方面没有发现显著差异.
结论:
- 患有心力衰竭的病史与减肥手术后重大术后发病率大幅增加有关.
- 建议在患有高血压的减肥手术患者进行手术前优化和警的术后监测.
- 需要进一步的研究,以建立最佳的外科手术期间的管理策略,对接受代谢手术的HF患者.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
262
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
262
01:30Heart Failure VII: Nursing Interventions
397
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
397
01:27Heart Failure I: Introduction
670
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
670
01:23Peripheral Artery Disease V: Postoperative Nursing Management
354
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
354
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:22Heart Failure Drugs: β-Blockers
737
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
737